Cure.

Zahi Fayad, Director of the BioMedical Engineering and Imaging Institute at Mount Sinai, breaks down why betting on yourself early — even when if you risk failing — compounds over time. Become a Cure member → wewillcure.com/membership Filmed at Cure Studios, New York City Subscribe to Cure's YouTube: https://lnkd.in/eCRU56wz

Cell and gene therapies still aren't reaching the people who need them, despite decades of promise. Cure member Irene Rombel is working to change that. As Co-Founder and CEO of BioCurie, she's building AI-driven software to fix the manufacturing bottlenecks that stall these treatments long after the science is ready. The work has landed the company a $9.3 million ARPA-H contract and top honors at two global innovation challenges. In a Q&A with Cure, Irene explains why she bet on process over discovery and what's next as BioCurie prepares to launch its first commercial product. Read the full interview here: https://lnkd.in/eZqXAbD2

Michelle Chen, Ph.D., CEO and President of Form Bio, breaks down the two biggest bottlenecks slowing AI in biopharma — proprietary data silos and undigitized records — and why solving them is one of the biggest opportunities in healthcare right now. Become a Cure member → wewillcure.com/membership Filmed at Cure Studios, New York City Subscribe to Cure's YouTube: https://lnkd.in/eCRU56wz

One of our favorite moments from last week’s Power of X Summit was the Catalytic Impact Foundation pitch competition, where five women’s health startups presented solutions addressing major gaps in care. It was even more meaningful to see Deepecho, a member of the Cure community, take the top spot and earn a $100K investment for its AI-powered ultrasound technology—built to materially improve maternal care. We caught up with Co-Founder Saad Slimani after the competition to get his first impressions. For founders looking to sharpen their own pitch, we go deeper in our Concept to Cure series with Deerfield’s Dave Greenwald—breaking down what actually earns investor conviction, from narrative to signal: https://lnkd.in/eFk3TDKV

Day 2 of The Power of X Summit: Women's Health Innovation Summit focused on reimbursement, care models, AI, wearables, diagnostics, and the future of the investment landscape. The morning included a powerful conversation on designing women-centered care models, followed by one of the day's most critical panels on reimbursement, the structural barrier that quietly determines whether innovation ever reaches patients. The takeaway? Reimbursement strategy must drive your regulatory approach from day one. The "Health Rebels Take on AI" fireside with Esther Dyson and Saranne Rothberg brought both humor and substance, including Saranne's study showing AI-powered interventions reduced depression by 18% and stress by 15% among advanced cancer patients, even during the pandemic. The Wearables panel showcased companies like OhmBody, Incora Health, and Doveras who are turning raw biometric data into clinically actionable insights. The Founder & Funder fireside chat between Sonal Pai of First Spark Ventures and Yana Aznavour, MD, PhD of Endometrics reframed the narrative: "We're not funding women's health companies — we're funding the next big revolution in diagnostics." And the closing panel delivered data that should end the nascent market argument for good. Anna Milik Jeter of AOA Dx shared that the sector has produced 24 unicorns, over $100B in exits, and 17x ROI versus the broader market. It's been incredible to see the women's health community in one room and we're eager to see where these conversations lead. WHH Women’s Health Horizons Jason Clark Dr. Bayo C. Annmarie Lyons Dawnette Lewis Emeline Aviki, MD, MBA Priya Bathija Valerie Palmieri Leslie Wise Jannine Versi Rebecca Bloom Gameto Geminii Health Glaucus ReConstruct Bio Sena Therapeutics Luba Perry, PhD Elisa Riedo Sunny Huang Christian Kramme, PhD Elizabeth Garner Komal Bajaj Kristen Dahlgren Bonnie Feldman, DDS, MBA Celina Gorre Rachel Braun Scherl Keara S. Amy Gaston Nara Lee

Day 1 of The Power of X Summit is in the books, and the momentum behind women's health innovation is undeniable. Cure CEO Seema Kumar and WHH Women’s Health Horizons CEO Jason Clark opened the conference with a straightforward point: this is one of the biggest unmet opportunities in healthcare. The Changemakers panel put real numbers behind that. More than $100B in exit value already realized. Investment up 55% in 2024. And a $360B global gap still sitting there. Piraye Beim’s recent exit with Celmatix Therapeutics came up as a moment that helped validate the space in a new way. The physician-entrepreneur panel showed a different angle: what happens when the people closest to patients are the ones building. Sophia Yen, MD, MPH of Pandia Health shared how a custom prescribing algorithm led to 93% patient satisfaction and 82% one-year retention, well above typical benchmarks. Later, the investment panel with Elizabeth Bailey of Foreground Capital and Maria Molland of Frazier Healthcare Partners made it clear that capital is starting to catch up. The afternoon featured several standout moments. The Catalytic Impact Foundation's pitch competition showcased presentations from five early-stage companies disrupting the industry, spanning from maternal health to osteoporosis care. Congratulations to runner-up Feminai and winner Deepecho, who are walking away with funding from CIF. Another highlight was hearing from Jennifer H. Mieres, MD on what it will take to advance cardiovascular care for women. More to come from Day 2! Andrea Olariu, MD, PhD, Liz Powell, Esq., MPH, Michael Annichine, Allison Mignone, Kanwal L. Haq, Stacey Brayboy, Joanne Stone, Amy Eskelsen, LCSW-S, CPHQ, MBA, Kimberly Wells, Amy G., Rachel Butler, Robert Wolk, Richard Lipkin, John O'Brien, MBA, ABV, Saad Slimani, Christine Rohan, Gloria K., Hunter Newman, PhD, Karny Ilan, MD, Nicole Notar, Christina Brinch Clark, Melindah Sharma, Sasha Schrode, Alan Garely, Barbara Hannah Grufferman

The Power of X Summit starts tomorrow, and we'll be tackling the questions of moving women’s health forward. We know the gaps well, now how do we close them? On Day 2 of the Summit, Delphine O’Rourke will moderate “The Future of Women’s Health: Closing the Gaps, Shaping What Comes Next,” with Anna Milik Jeter, Monica Cepak, and Monica Malowney, M.P.H., focusing on where the biggest opportunities lie and how the next wave of innovation will take shape. Join us at the Summit! 📍 March 18–19, 2026 📍 Cure, 345 Park Avenue South, NYC 👉 Register: https://lnkd.in/gV-CrP8n

Progress in women’s health doesn’t happen in silos. It takes coordination across science, policy, advocacy, and industry. That’s the focus of “Changemakers: Leading the Charge in Advancing Women’s Health,” a panel taking place at the Power of X Summit on March 18. The talk is moderated by Seema Kumar, with Andrea Olariu, MD, PhD, Liz Powell, Esq., MPH, Piraye Beim, PhD, and Michael Annichine. Join us at the Summit! 📍 March 18–19, 2026 📍 Cure, 345 Park Avenue South, NYC 👉 Register: https://lnkd.in/gV-CrP8n

We were proud to host this important conversation during #CSW70, bringing together leaders across government, life sciences, finance, and healthcare to explore how cross-sector collaboration can accelerate progress in women’s health.

We look forward to welcoming Allison Mignone to our Power of X stage next week for a fireside chat with Cure CEO Seema Kumar. A philanthropist and patient advocate, Allison founded the Mignone Women’s Health Collaborative at NYU Langone Health, a $50 million initiative focused on building more integrated, patient-centered care for women. And her work is deeply personal: after surviving triple-negative breast cancer, she has become a strong voice for expanding access and rethinking how women’s health care is delivered. At Power of X, which we are hosting in partnership with WHH Women’s Health Horizons, Allison and Seema will discuss the role philanthropy, advocacy, and health systems can play in moving women’s health forward, and why more integrated models of care are essential to making real progress. 📍 March 18–19, 2026 📍 Cure, 345 Park Avenue South, NYC 👉 Register: https://lnkd.in/gV-CrP8n